CIR SPA COMPAGNIE INDUSTRIAL financials
CIR SPA COMPAGNIE INDUSTRIAL
Country: IT Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
5493003VOSQJSPCM0T38 ISIN: IT0000070786 Financial statements
(EUR, as reported — unscaled; 98 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €1.82B | €1.79B |
| Other income | €29.7M | €34.6M |
| Employee benefits expense | €600.6M | €586.0M |
| Raw materials & consumables used | €636.6M | €663.8M |
| Depreciation & amortisation | €172.1M | €172.0M |
| Operating profit (EBIT) | €100.0M | €66.6M |
| Profit before tax | €81.0M | €23.8M |
| Income tax expense | €24.3M | €11.2M |
| Profit for the year | €200.1M | €66.9M |
| — attributable to owners | €132.2M | €32.8M |
| — attributable to NCI | -€67.9M | -€34.1M |
| Total comprehensive income | €202.2M | €44.6M |
| Per share | ||
| Basic EPS | €0.12 | €0.03 |
| Diluted EPS | €0.12 | €0.03 |
| Cash flow statement | ||
| Net cash from operating activities | €180.9M | €122.6M |
| Net cash from investing activities | -€49.0M | -€137.0M |
| Net cash from financing activities | -€502.9M | -€123.9M |
| Dividends paid | €67.1M | €6.8M |
| Net change in cash | -€371.0M | -€138.3M |
| Balance sheet | ||
| Total assets | €2.76B | €3.23B |
| Non-current assets | €1.91B | €2.20B |
| Property, plant & equipment | €526.1M | €613.2M |
| Right-of-use assets | €781.2M | €821.4M |
| Intangible assets & goodwill | €480.9M | €577.2M |
| Current assets | €847.6M | €1.02B |
| Inventories | €89.3M | €143.6M |
| Trade & other receivables | €179.1M | €254.7M |
| Cash & equivalents | €130.6M | €150.0M |
| Total equity | €1.07B | €1.03B |
| — attributable to owners | €791.2M | €753.6M |
| Non-controlling interests | €279.5M | €281.2M |
| Non-current liabilities | €1.08B | €1.38B |
| Current liabilities | €603.5M | €812.8M |
| Trade & other payables | €241.4M | €326.3M |
| Deferred tax liabilities | €35.8M | €48.2M |
| Derived metrics | ||
| Operating margin | 5.5% | 3.7% |
| Net margin | 11.0% | 3.7% |
| Return on equity | 18.7% | 6.5% |
| Cash conversion ratio | 0.90× | 1.83× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense | €172.1M | €172.0M |
| Adjustments For Fair Value Gains Losses | -€15.7M | -€5.1M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€4.4M | -€333.0K |
| Adjustments For Sharebased Payments | €1.6M | €1.7M |
| Basic Earnings Loss Per Share From Continuing Operations | €0.05 | €0.01 |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €130.3M | €149.3M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €1.3M |
| Changes In Inventories of Finished Goods and Work In Progress | -€2.9M | -€2.7M |
| Comprehensive Income Attributable To Noncontrolling Interests | €68.8M | €24.4M |
| Comprehensive Income Attributable To Owners of Parent | €133.4M | €20.2M |
| Deferred Tax Assets | €47.4M | €72.8M |
| Diluted Earnings Loss Per Share From Continuing Operations | €0.05 | €0.01 |
| Equity and Liabilities | €2.76B | €3.23B |
| Finance Costs Paid Classified As Operating Activities | -€21.6M | -€37.4M |
| Finance Income | €20.6M | €21.2M |
| Financial Assets At Fair Value Through Profit Or Loss Classified As Held For Trading | €206.2M | €315.3M |
| Gains Losses On Cash Flow Hedges Before Tax | -€2.7M | -€2.5M |
| Gains Losses On Exchange Differences On Translation Before Tax | €3.2M | -€16.9M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | -€659.0K | -€600.0K |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €298.0K | €2.1M |
| Income Taxes Paid Refund | -€16.4M | -€13.3M |
| Increase Decrease In Cash and Cash Equivalents | -€19.1M | -€68.4M |
| Increase Decrease In Working Capital | €40.5M | €36.0M |
| Increase Decrease Through Change In Equity of Subsidiaries | -€1.0M | €5.5M |
| Increase Decrease Through Sharebased Payment Transactions | €1.4M | €1.3M |
| Increase Decrease Through Transfers and Other Changes Equity | €0 | €0 |
| Increase Decrease Through Treasury Share Transactions | -€99.7M | -€14.0M |
| Investment Accounted For Using Equity Method | €747.0K | €670.0K |
| Investment Property | €2.3M | €2.4M |
| Issue of Equity | €0 | €0 |
| Issued Capital | €420.0M | €420.0M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | — | €11.0M |
| Noncurrent Provisions For Employee Benefits | €34.8M | €42.5M |
| Other Adjustments For Noncash Items | €1.3M | -€22.4M |
| Other Comprehensive Income | €2.1M | -€22.3M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €1.2M | -€1.4M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €1.1M | -€18.8M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €915.0K | -€3.5M |
| Other Current Financial Assets | €17.1M | €16.0M |
| Other Current Financial Liabilities | €61.3M | €74.0M |
| Other Current Nonfinancial Assets | €65.4M | €67.3M |
| Other Current Nonfinancial Liabilities | €139.8M | €217.0M |
| Other Expense By Nature | €72.9M | €63.0M |
| Other Finance Cost | -€65.4M | -€66.7M |
| Other Inflows Outflows of Cash Classified As Financing Activities | €0 | €0 |
| Other Longterm Provisions | €7.7M | €9.3M |
| Other Noncurrent Financial Assets | €63.1M | €72.9M |
| Other Noncurrent Financial Liabilities | €208.4M | €345.0M |
| Other Noncurrent Nonfinancial Assets | €9.1M | €36.1M |
| Other Noncurrent Nonfinancial Liabilities | €40.6M | €57.4M |
| Other Reserves | €196.8M | €298.2M |
| Other Shortterm Provisions | €53.8M | €50.5M |
| Payments To Acquire Or Redeem Entitys Shares | €99.7M | €14.0M |
| Proceeds From Issuing Shares | €0 | €0 |
| Profit Loss From Continuing Operations | €56.7M | €12.6M |
| Profit Loss From Discontinued Operations | €143.4M | €54.3M |
| Retained Earnings | €42.2M | €2.6M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Net of Tax | €0 | €0 |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €77.0K | €40.0K |
Methodology
Every line item above is a fact tagged in CIR SPA COMPAGNIE INDUSTRIAL's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.